Monoclonal Anti-pre-Gc protein (SFTS virus (HN6)) Antibody, Mouse IgG1 (13E1)

Cat. No. / Size
Price
Availability
Qty
PRN-Y315-100ug
$415.00
In Stock - Delivery in 1-2 business days
PRN-Y315-1mg
$2,735.00
In Stock - Delivery in 2 weeks
PRN-Y315
Sub-Total :
$ 0
Customize Product Request Quote
Contact Us
Contact Us
Sub-Total:
$ 0
  • Product Details
  • Performance Data
  • Reviews & Citations
  • Important Statement
  • Resources
Source

Monoclonal Anti-pre-Gc protein (SFTS virus (HN6)) Antibody, Mouse IgG1 (13E1) (Cat. No. PRN-Y315) is a mouse monoclonal antibody produced from a hybridoma generated by fusion of SP2/0 myeloma cells with mouse B lymphocytes.

Antibody Type

Hybridoma Monoclonal

Clone

13E1

Isotype

Mouse IgG1, Kappa

Host Species

Mouse

Reactivity

Virus

Immunogen

Recombinant SFTS virus pre-Gc Protein (HN6) is expressed from human 293 cells

Specificity

Specifically recognizes SFTS virus pre-Gc Protein (HN6).

Application
Application
Recommended Use
ELISA
0.2-2 μg/mL

* Recommended dilutions are for reference only. Optimal working concentrations may vary depending on your consumables, reagents, and assay conditions. We recommend optimizing for your specific system. No warranty is made regarding performance at any specific dilution.

Purification

Protein A purified.

Concentration

Please refer to the Certificate of Analysis (CoA).

Form

Lyophilized

Formulation

Lyophilized from a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.

Please contact us for customized product forms or formulations.

Reconstitution

Please refer to the Certificate of Analysis (CoA) for specific instructions.

Shipping

Lyophilized product is shipped at ambient temperature.

Storage

For long term storage, the product should be stored in a lyophilized state at -20°C or lower.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • -20°C to -70°C for 12 months in lyophilized state;
  • -70°C for 3 months under sterile conditions after reconstitution.
Notices

Product Specific Notices: For research use only.

Background

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging viral hemorrhagic fever (VHF) endemic to China, South Korea, Japan, and Vietnam. Severe fever with thrombocytopenia syndrome (SFTS) is an infectious disease with a high fatality rate, caused by SFTS virus (SFTSV). To our knowledge, no efficient SFTSV vaccine exists.